•   
  •   

World Covid-19: here is what the authorization of the Johnson & Johnson vaccine in the United States will change

17:15  28 february  2021
17:15  28 february  2021 Source:   lejdd.fr

Australia's COVID-19 vaccine rollout now has some certainty but there are still many unknowns

  Australia's COVID-19 vaccine rollout now has some certainty but there are still many unknowns The announcements about Australia's COVID-19 vaccine rollout have been travelling at warp speed this week and although there are now some guarantees, there are still many unknowns."The eagle has landed," Health Minister Greg Hunt announced on Monday, declaring 142,000 doses of the Pfizer vaccine had touched down in Australia — after much nervousness.

Les Etats-Unis ont accordé samedi une autorisation en urgence au vaccin de Johnson & Johnson contre le Covid-19. En Europe, où l'agence du médicament rendra son avis début mars, les première doses pourraient être disponibles dans un mois. © Reuters

The United States on Saturday granted an emergency authorization for the Johnson & Johnson vaccine against the Covid-19 . In Europe, where the drug agency will issue its opinion in early March, the first doses could be available in a month.

A third vaccine in the United States. The American Medicines Agency (FDA) gave its approval on Saturday: after the vaccines from Pfizer / BioNTech and Moderna, it is the turn of that of Johnson & Johnson to obtain an emergency authorization in the United States . Friday, a committee of experts had recommended the marketing of the vaccine of the American company following a detailed study of data from clinical trials conducted on more than 43,000 people.

Australians banned from the PUB if they refuse coronavirus vaccine

  Australians banned from the PUB if they refuse coronavirus vaccine Safe Work Australia said while it's unlikely companies will be forced to ask customers for proof of vaccination under current work health and safety laws, they are free to do so if they please. The safety regulator recommended that businesses - including cafes, restaurants and bars - consider taking further precautionary action once the vaccine is administered.

Differences with Pfizer and Moderna. Johnson & Johnson Serum is a single dose vaccine called Janssen Covid-19 , which can be stored at refrigerator temperatures. It is a viral vector vaccine, which uses another weakly virulent virus as a carrier, transformed to add genetic instructions from part of the virus responsible for Covid-19. Once in the cells, a typical Sars-CoV-2 protein is produced, educating the immune system to recognize it. In clinical trials, the vaccine was 85.9% effective against severe forms of the disease.

A boost for the American campaign. So far, about 15% of Americans have already received at least one dose of the vaccine. The campaign should accelerate further with the arrival of this third serum. At least three million doses of the "J&J" product are ready for distribution as early as next week, according to the US government. Johnson & Johnson has committed to ship 100 million doses to the United States by the end of June.

The growing evidence that the Covid-19 vaccines can reduce transmission, explained

  The growing evidence that the Covid-19 vaccines can reduce transmission, explained Here’s what we know about how the vaccines protect against spread of the virus.Despite that fact, public health officials and media outlets have been warning that vaccinated people need to behave largely how they did before they were vaccinated. That’s because we don’t know as much about the vaccines’ effectiveness at preventing transmission to others.

With 600 million doses ordered in total from Pfizer and Moderna, the United States will already have, by the end of July, enough vaccines to immunize almost the entire population. "This is great news for all Americans, and an encouraging step in our efforts to end the crisis," Joe Biden said in a statement. "But we cannot let our guard down or take it for granted that victory is inevitable," he added.

Few countries already use it. South Africa became the first country to administer the Johnson & Johnson vaccine in mid-February, of which it has ordered a total of 9 million doses. The first vaccinations are intended for 1.2 million health workers. This week, Bahrain also authorized the serum of the American firm in its territory.

And in Europe? The European Medicines Agency (EMA) reported on February 16 that Johnson & Johnson had applied for authorization of their vaccine. She could issue an opinion "in mid-March 2021", or even as early as March 11, according to the Bloomberg agency. If a positive opinion were given, the Johnson & Johnson serum would become the fourth authorized in Europe (after Pfizer, Moderna and Astrazeneca).

The European Commission has ordered 200 million doses of the Janssen vaccine, with an option for an additional 200 million. Half of this order, or 100 million doses, must be delivered by June if the vaccine is authorized. The Minister for Industry, Agnès Pannier-Runacher, indicated on France 3 on Sunday that the first doses will be available at the end of March-beginning of April in France.

Why this is important. With the authorization of this new vaccine, the world will be able to rely on new production capacities and, therefore, on more doses. Beyond this obvious good news, Johnson & Johnson's serum will also facilitate logistics since it only requires a single dose, which can be stored in a simple refrigerator. At a time when the shortages of syringes and super-freezers are worrying, this is a major asset.

Black, Latino Californians Given 20% Of State's COVID Vaccines, But Make Up 42% of Population .
California Gov. Gavin Newsom has called equity his "North Star," but the vaccine rollout is leaving the state's largest, most vulnerable communities behind.African Americans have received 3 percent of vaccine doses while they make up 6 percent of the state, according to the Associated Press. Latinos, who make up 39 percent of the state, have received 17 percent of doses. The vaccination gap is much narrower for white Californians, who make up 36 percent of the state's population. State health data shows that 32 percent of white people in the state have already received shots.

usr: 1
This is interesting!